Detalhe da pesquisa
1.
Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma.
Cell
; 179(2): 561-577.e22, 2019 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31585088
2.
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma.
Cell
; 169(7): 1327-1341.e23, 2017 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28622513
3.
Deep whole-genome analysis of 494 hepatocellular carcinomas.
Nature
; 627(8004): 586-593, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38355797
4.
NAMPT promotes the malignant progression of HBV-associated hepatocellular carcinoma through activation of SREBP1-mediated lipogenesis.
FASEB J
; 38(2): e23444, 2024 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38252081
5.
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma.
Nature
; 567(7747): 257-261, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30814741
6.
Functional genetic variants of the disulfidptosis-related INF2 gene predict survival of hepatitis B virus-related hepatocellular carcinoma.
Carcinogenesis
; 45(4): 199-209, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38270181
7.
Hepatitis B doubly spliced protein (HBDSP) promotes hepatocellular carcinoma cell apoptosis via ETS1/GATA2/YY1-mediated p53 transcription.
J Virol
; 97(11): e0108723, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37929990
8.
Mdm2 phosphorylation by Akt regulates the p53 response to oxidative stress to promote cell proliferation and tumorigenesis.
Proc Natl Acad Sci U S A
; 118(4)2021 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33468664
9.
[Overexpression of tuftelin and KLF-5 and its clinicopathological features in hepatitis B virus-related hepatocellular carcinoma].
Zhonghua Gan Zang Bing Za Zhi
; 32(2): 148-154, 2024 Feb 20.
Artigo
em Zh
| MEDLINE | ID: mdl-38514264
10.
Association of hepatitis B virus DNA levels with overall survival for advanced hepatitis B virus-related hepatocellular carcinoma under immune checkpoint inhibitor therapy.
Cancer Immunol Immunother
; 72(2): 385-395, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35907016
11.
Low Level of Hepatitis B Viremia Compared With Undetectable Viremia Increases the Risk of Hepatocellular Carcinoma in Patients With Untreated Compensated Cirrhosis.
Am J Gastroenterol
; 118(6): 1010-1018, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36622283
12.
Modulation of SOCS3 Levels via STAT3 and Estrogen-ERαp66 Signaling during Hepatitis E Virus Replication in Hepatocellular Carcinoma Cells.
J Virol
; 96(19): e0100822, 2022 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36102649
13.
Hepatitis B Virus Small Envelope Protein Promotes Hepatocellular Carcinoma Angiogenesis via Endoplasmic Reticulum Stress Signaling To Upregulate the Expression of Vascular Endothelial Growth Factor A.
J Virol
; 96(4): e0197521, 2022 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34910612
14.
Hepatitis C virus infection restricts human LINE-1 retrotransposition in hepatoma cells.
PLoS Pathog
; 17(4): e1009496, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33872335
15.
Statin use is associated with better post-operative prognosis among patients with hepatitis B virus-related hepatocellular carcinoma.
Eur J Clin Invest
; 53(4): e13936, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36504405
16.
Elucidating the role of missense SNP of protein kinase C epsilon in HCV-induced hepatocellular carcinoma.
BMC Cancer
; 23(1): 147, 2023 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36782184
17.
Primary non-response to antiviral therapy affects the prognosis of hepatitis B virus-related hepatocellular carcinoma.
BMC Cancer
; 23(1): 564, 2023 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37340357
18.
Efficacy and safety of PD-1/PD-L1 inhibitors combined with anti-angiogenic therapy for the unresectable hepatocellular carcinoma and the benefit for hepatitis B virus etiology subgroup: a systematic review and meta-analysis of randomized controlled trials.
BMC Cancer
; 23(1): 474, 2023 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37226111
19.
HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population.
Virol J
; 20(1): 283, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38037048
20.
Nuclear translocation of YAP drives BMI-associated hepatocarcinogenesis in hepatitis B virus infection.
Liver Int
; 43(9): 2002-2016, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37312627